Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor-Reference-Cited by-同舟云学术

Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor

Published:2017-12 Issue:6 Volume:96 Page:1358-1372.e4
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Moehle Mark S.,Pancani Tristano,Byun Nellie,Yohn Samantha E.,Wilson George H.,Dickerson Johnathan W.,Remke Daniel H.,Xiang Zixiu,Niswender Colleen M.,Wess Jürgen,Jones Carrie K.,Lindsley Craig W.,Rook Jerri M.,Conn P. Jeffrey

Funder

Dystonia Medical Research Foundation

Mahlon DeLong Young Investigator Award

NIH

Publisher

Elsevier BV

Subject

General Neuroscience

Reference74 articles.

1. The functional anatomy of basal ganglia disorders;Albin;Trends Neurosci.,1989

2. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions;Alexander;Prog. Brain Res.,1990

3. Temporal and spatial characteristics of tonically active neurons of the primate’s striatum;Aosaki;J. Neurophysiol.,1995

4. Acetylcholine-dopamine balance hypothesis in the striatum: an update;Aosaki;Geriatr. Gerontol. Int.,2010

5. The physiology, signaling, and pharmacology of dopamine receptors;Beaulieu;Pharmacol. Rev.,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment;Clinical Drug Investigation;2024-06-21

2. Mechanisms of GNAL linked dystonia;Dystonia;2024-05-09

3. The stereoselective pharmacokinetics of the desmethyl‐phencynonate hydrochloride in beagle dogs;Chirality;2024-05

4. Activation of M₄ muscarinic receptors in the striatum reduces tic‐like behaviours in two distinct murine models of Tourette syndrome;British Journal of Pharmacology;2024-04-30

5. Rostral Pedunculopontine Nucleus Infusion of M₄Positive Allosteric Modulator VU0467154 Augments L-DOPA Effects in Hemiparkinsonian Rats;2024-04-20